We are live on
!
Find out more
EAM
Eventide Asset Management Portfolio holdings
AUM
$7.48B
1-Year Est. Return
104.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.12%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$6.05B
AUM Growth
-$355M
(-5.5%)
Cap. Flow
-$238M
Cap. Flow
% of AUM
-3.93%
Top 10 Holdings %
Top 10 Hldgs %
22.18%
Holding
314
New
46
Increased
155
Reduced
70
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GeneDx Holdings
WGS
|
+$41.9M |
| 2 |
Generac Holdings
GNRC
|
+$40.9M |
| 3 |
Vaxcyte
PCVX
|
+$24.8M |
| 4 |
Teradyne
TER
|
+$24.8M |
| 5 |
UL Solutions
ULS
|
+$21.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mirum Pharmaceuticals
MIRM
|
+$64.4M |
| 2 |
GE Vernova
GEV
|
+$42.1M |
| 3 |
Inspire Medical Systems
INSP
|
+$40.6M |
| 4 |
RNAM
Avidity Biosciences
RNAM
|
+$37.8M |
| 5 |
Lithia Motors
LAD
|
+$33.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.12% |
| 2 | Industrials | 19.41% |
| 3 | Technology | 15.63% |
| 4 | Energy | 7.14% |
| 5 | Consumer Discretionary | 5.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Guardant Health
GH
$22.6B
| $218M | 3.61% |
2,362,379
-148,712
| -6% | -$14.9M |
|
2
Trane Technologies
TT
$100B
| $169M | 2.8% |
406,555
+3,281
| +0.8% | +$1.39M |
|
3
Lam Research
LRCX
$399B
| $147M | 2.42% |
688,402
+19,313
| +3% | +$4.32M |
|
|
4
Mirum Pharmaceuticals
MIRM
$6.08B
| $130M | 2.15% |
1,408,871
-684,711
| -33% | -$64.4M |
|
5
Targa Resources
TRGP
$62B
| $126M | 2.08% |
502,287
+21,737
| +5% | +$4.71M |
|
6
Xometry
XMTR
$5.52B
| $121M | 2% |
2,960,239
+24,113
| +0.8% | +$1.28M |
|
|
7
GE Vernova
GEV
$254B
| $116M | 1.91% |
133,200
-53,922
| -29% | -$42.1M |
|
8
Old Dominion Freight Line
ODFL
$41.5B
| $115M | 1.91% |
591,691
-18,953
| -3% | -$3.53M |
|
9
Scholar Rock
SRRK
$7.22B
| $108M | 1.78% |
2,197,385
-233,948
| -10% | -$10.5M |
|
10
argenx
ARGX
$66.2B
| $91.7M | 1.52% |
125,657
+4,436
| +4% | +$3.47M |
|
11
ASML
ASML
$666B
| $89.9M | 1.49% |
68,110
+1,290
| +2% | +$1.77M |
|
12
iRhythm Holdings
IRTC
$3.83B
| $89.8M | 1.48% |
760,825
+68,339
| +10% | +$9.86M |
|
13
Insmed
INSM
$26.5B
| $89.3M | 1.48% |
546,310
+62,721
| +13% | +$9.64M |
|
14
Axsome Therapeutics
AXSM
$10.8B
| $87.8M | 1.45% |
519,558
-51,668
| -9% | -$8.92M |
|
|
15
Vaxcyte
PCVX
$9.1B
| $79.8M | 1.32% |
1,374,292
+457,177
| +50% | +$24.8M |
|
16
Entergy
ETR
$49.7B
| $76.5M | 1.27% |
682,847
+9,765
| +1% | +$982K |
|
17
Vistra
VST
$46.9B
| $74M | 1.22% |
492,711
+5,075
| +1% | +$821K |
|
18
United Rentals
URI
$64.6B
| $71.2M | 1.18% |
97,795
+1,855
| +2% | +$1.56M |
|
19
Liberty Energy
LBRT
$3.14B
| $69.2M | 1.14% |
2,403,098
+432,639
| +22% | +$11M |
|
20
Toast
TOST
$20.3B
| $66M | 1.09% |
2,488,669
+2,629
| +0.1% | +$78.5K |
|
21
Mettler-Toledo International
MTD
$28.2B
| $64M | 1.06% |
50,751
+493
| +1% | +$665K |
|
22
Monolithic Power Systems
MPWR
$64.4B
| $63.4M | 1.05% |
58,154
-10,219
| -15% | -$11.2M |
|
23
Royalty Pharma
RPRX
$27.6B
| $62.6M | 1.04% |
1,312,534
+15,708
| +1% | +$688K |
|
24
nVent Electric
NVT
$25.2B
| $61.6M | 1.02% |
523,557
+8,667
| +2% | +$984K |
|
25
Williams Companies
WMB
$90.7B
| $60.5M | 1% |
832,248
+39,088
| +5% | +$2.71M |
|
Similar funds
S
CCM
O
HI
HPC
FPP
RIG
TAM
Eventide Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Eventide Asset Management held 314 positions worth $6.05B, down 5.5% from $6.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Eventide Asset Management withdrew a net $238M in Q1 2026, closing 36 positions and reducing 70 holdings. Its most notable exit was Inspire Medical Systems, an estimated $40.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 42% a quarter earlier, followed by Industrials and Technology.
Against the trend, Eventide Asset Management opened a new position in GeneDx Holdings worth $29.5M.
- Eventide Asset Management's largest Q1 2026 buy was GeneDx Holdings: 459,015 shares worth $29.5M.
- Eventide Asset Management added most to Generac Holdings in Q1 2026, an estimated $40.9M increase.
- Eventide Asset Management's biggest Q1 2026 reduction was Mirum Pharmaceuticals, cutting an estimated $64.4M.
- Eventide Asset Management fully exited Inspire Medical Systems in Q1 2026, selling an estimated $40.6M.
- Eventide Asset Management's ten largest holdings make up 22% of its $6.05B portfolio in Q1 2026.
- Eventide Asset Management opened 46 new positions and closed 36 in Q1 2026.
- Eventide Asset Management's portfolio value fell 5.5% quarter-over-quarter to $6.05B.
Based on Eventide Asset Management's 13F filing for Q1 2026, filed 15 May 2026.